Abstract
Long-chain fatty acids (LCFA) are the major energy substrate for heart and their oxidation is important for achieving maximal cardiac work. However, the mechanism of uptake of LCFA by myocardium has not been clarified. We previously reported that bovine myocardial LCFA transporter has a sequence homology to human CD36. Clinically, total defect of myocardial uptake of radiolabeled long-chain fatty acid analog [123I-BMIPP: Iodine-123 15-(p-iodophenyl)-(R,S)-methylpentadecanoic acid] has been reported in some restricted cases, but the etiology has not been clarified. In the present study, we analyzed CD36 expression and CD36 gene in subjects who showed total lack of myocardial 123I-BMIPP accumulation, and, vice versa, evaluated myocardial 123I-BMIPP uptake in subjects with CD36 deficiency. Four unrelated subjects were evaluated; Two were found to have negative myocardial LCFA accumulation by 123I-BMIPP scintigraphy, after which the expression of CD36 on their platelets and monocytes was analyzed. Remaining two subjects were identified as CD36 deficiency by screening, then 123I-BMIPP scintigraphy was performed. Expression of CD36 on platelets and monocytes was measured by flow cytometric analysis. The molecular defects responsible for CD36 deficiency was detected by allele-specific restriction enzyme analysis. CD36 expression was totally deficient in all 4 subjects on both platelets and monocytes. Two subjects were homozygous for a 478C→T mutation. One was heterozygous for the dinucleotide deletion of exon V and single nucleotide insertion of exon X, and remaining one was considered to be heterozygous for the dinucleotide deletion of exon V and an unknown gene abnormality. All cases demonstrated a completely negative accumulation of myocardial LCFA despite of normal myocardial perfusion, which was evaluated by thallium scintigraphy. In addition, all cases demonstrated apparently normal hepatic LCFA accumulation Thus, these findings suggested that CD36 acts as a major myocardial specific LCFA transporter in humans.
Similar content being viewed by others
References
Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grialdi PA: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665–17668, 1993
Tanaka T, Kawamura K: Isolation of myocardial membrane long-chain fatty acid-binding protein; homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids. J Mol Cell Cardiol 27: 1613–1622, 1995
Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA: Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction and transfusion medicine. Blood 80: 1105–1115, 1992
Tandon NN, Kralisz NU, Jamieson GA: Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264: 7576–7583, 1989
Asch AS, Barnwell J, Silverstein RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest 79: 1054–1061, 1987
Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811–11816, 1993
Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, Nakase T, Sekiguchi S: A new platelet-specific antigen, Naka involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 57: 213–217, 1989
Tomiyama Y, Take H, Ikeda H, Mitani T, Furubayashi T, Mizutani H, Yamamoto N, Tandon NN, Sekiguchi S, Jamieson GA, Kurata Y, Yonezawa T, Tarui S: Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood 75: 684–687, 1990.
Kashiwagi H, Honda S, Tomiyama Y, Mizutani H, Take H, Honda Y, Kosugi S, Kanayama Y, Kurata Y, Matsuzawa Y: A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV. Thromb Haemostas 69: 481–484, 1993
Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Kanayama Y, Kurata Y, Matsuzawa Y: Identification of molecular defects in a subject with type I CD36 deficiency. Blood 83: 3545–3552, 1994
Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanayama Y, Kurata Y, Matsuzawa Y: Molecular basis of CD36 deficiency; evidence that a 478C-T substitution (proline90–serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 95: 1040–1046, 1995
Kashiwagi H, Tomiyama Y, Nozaki S, Honda S, Kosugi S, Shiraga M, Nakagawa T, Nagao N, Kanakura Y, Kurata Y, Matstizawa Y: A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb Vasc Biol 16: 1026–1032, 1996
Take H, Kashiwagi H, Tomiyama Y, Honda S, Honda Y, Mizutani H, Furubayashi T, Karasuno T, Nishiura T, Kanayama Y, Kurata Y, Matsuzawa Y: Expression of GPIV and Nak' antigen on monocytes in Naka negative subjects whose platelets lack GPIV. Brit J Haematol 84: 387–391, 1993
Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K: Platelet glycoprotein IV (CD36) deficiency is associated with the absence (Type I) or the presence (Type II) of glycoprotein IV on monocytes. Blood 83: 392–397, 1994
Knapp Mr, Kropp J: Iodine-123–labeled fatty acids for myocardial single photonemission tomography: Current status and future perspectives. Eur J Nucl Med 22: 361–381, 1995
Knapp Mr, Franken P, Kropp J: Cardiac SPECT with iodine-123–labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 36: 1022–1030, 1995
Tateno M, Tamaki N, Yukihiro M, Kudoh T, Hattori N, Tadamura E, Nohara-R, Suzuki T, Endo K, Konishi J: Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 37: 1981–1985, 1996
Chen SL, Uehara T, Morozumi T, Yamagami H, Kusuoka H, Nishimura T: Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: Assessment by radial long-axis SPET. Nucl Med Commun 16: 336–343, 1995
Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M: Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15–(p-iodophenyl)-3–R, S-methylpentadecanoic acid (123I-BMIPP). Nucl Med Commun 15: 441–447, 1994
Hwang EHH, Yamashita A, Takemori H, et al.: Absent myocardial I-123 BMIPP uptake in a family. Ann Nucl Med 10: 445–448, 1996
Kudoh T, Tamaki N, Magata Y, Konishi J, Nohara R, Iwasaki A, Ono S, Ohtake Y, Sugihara H, Kuze K, Tsujimura Y, Miyazaki T: Metabolism substrate with negative myocardial uptake of iodine-123–BMIPP. J Nucl Med 38: 548–553, 1997
Tanaka T, Sohmiya K, Kawamura K: Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29: 121–127, 1997
Van der Vusse GJ, Glatz JFC, Starn HCG, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72: 881–940, 1992
Rodrigues B, Cam MC, McNeffi JH: Myocardial substrate metabolism; implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169–179, 1995
DeGrella RF, Light RJ: Uptake and metabolism of fatty acids by dispersed adult rat heart myocytes. II. Inhibition by albumin and fatty acid homologues, and the effect of temperature and metabolic reagents. J Biol Chem 255: 9739–9745, 1980
Rose H, Hennecke T, Kammermeier H: Sarcolemmal fatty acid transfer in isolated cardiomyocytes governed by albumin/membrane-lipid partition. J Mol Cell Cardiol 22: 833–892, 1990
Harmon CM, Luce P, Beth AH, Abumrad NA: Labeling of adipocyte membranes by sulfo-N-succinimidyl derivates of long-chain fatty acids: Inhibition of fatty acid transporter. J Membrane Biol 121: 261–268, 1991
Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD: Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci USA 82: 4–8, 1985
Stremmel W, Lotz G, Strohmeyer G, Berk PD: Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest 75: 1068–1076, 1985
Stremmel W: Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport system. J Clin Invest 81: 844–853, 1988
Fujii S, Kawaguchi H, Yasuda H: Purification of high affinity fatty acid receptors in rat myocardial sarcolemmal membranes. Lipids 22: 544–546, 1987
Schaffer JE, Lodish HF: Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79: 427–436, 1994
Harmon CM, Aburnrad NA: Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and amino-terminal sequence of an 88–M protein implicated in transport of long-chain fatty acids. J Mem Biol 133: 43–49, 1993
Abumrad NA, Park JH, Park CR: Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J Biol Chem 259: 8945–8953, 1984
Kurata C, Kobayashi A, Yamazaki N: Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 30: 80–87, 1989
Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H: Heterogeneous myocardial distribution of iodine-123 15-(piodophenyl)-3–R, S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 19: 775–782, 1992
Kusaka Y, Tanaka T, Okamoto F, Terasaki F, Matsunaga Y, Miyazaki H, Kawamura K: Effect of sulfo-N-succinimidyl palmitate on the rat heart: Myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol 27: 1605–1612, 1995
Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M, Koizumi T, Nikaido H, Hayakawa J, Kuwajima, M, Saheki T: Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 326: 267–271, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nozaki, S., Tanaka, T., Yamashita, S. et al. CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 192, 129–135 (1999). https://doi.org/10.1023/A:1006816702425
Issue Date:
DOI: https://doi.org/10.1023/A:1006816702425